Successful Gene Therapy in Older Rpe65-Deficient Dogs Following Subretinal Injection of an Adeno-Associated Vector Expressing RPE65

被引：30

作者：

Annear, Matthew J. ^{[1
]}

Mowat, Freya M. ^{[1
,3
]}

Bartoe, Joshua T. ^{[1
]}

Querubin, Janice ^{[1
]}

Azam, Selina A. ^{[3
]}

Basche, Mark ^{[3
]}

Curran, Paul G. ^{[2
]}

Smith, Alexander J. ^{[3
]}

Bainbridge, James W. B. ^{[3
]}

Ali, Robin R. ^{[3
]}

Petersen-Jones, Simon M. ^{[1
]}

机构：

[1] Michigan State Univ, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA

[2] Michigan State Univ, Ctr Stat Consulting, E Lansing, MI 48824 USA

[3] UCL, Inst Ophthalmol, Dept Genet, London EC1V 9EL, England

来源：

HUMAN GENE THERAPY | 2013年 / 24卷 / 10期

关键词：

LEBER CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; BRIARD DOGS; NIGHT BLINDNESS; RESTORES VISION; CANINE MODEL; ANIMAL-MODEL; MOUSE MODEL; MUTATIONS; DYSTROPHY;

D O I：

10.1089/hum.2013.146

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Young Rpe65-deficient dogs have been used as a model for human RPE65 Leber congenital amaurosis (RPE65-LCA) in proof-of-concept trials of recombinant adeno-associated virus (rAAV) gene therapy. However, there are relatively few reports of the outcome of rAAV gene therapy in Rpe65-deficient dogs older than 2 years of age. The purpose of this study was to investigate the success of this therapy in older Rpe65-deficient dogs. Thirteen eyes were treated in dogs between 2 and 6 years old. An rAAV2 vector expressing the human RPE65 cDNA driven by the human RPE65 promoter was delivered by subretinal injection. Twelve of the 13 eyes had improved retinal function as assessed by electroretinography, and all showed improvement in vision at low lighting intensities. Histologic examination of five of the eyes was performed but found no correlation between electroretinogram (ERG) rescue and numbers of remaining photoreceptors. We conclude that functional rescue is still possible in older dogs and that the use of older Rpe65-deficient dogs, rather than young Rpe65-deficient dogs that have very little loss of photoreceptors, more accurately models the situation when treating human RPE65-LCA patients.

引用

页码：883 / 893

页数：11

共 45 条

[1] Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness [J].

Acland, GM ;

Aguirre, GD ;

Bennett, J ;

Aleman, TS ;

Cideciyan, AV ;

Bennicelli, J ;

Dejneka, NS ;

Pearce-Kelling, SE ;

Maguire, AM ;

Palczewski, K ;

Hauswirth, WW ;

Jacobson, SG .

MOLECULAR THERAPY, 2005, 12 (06) :1072-1082

[2] Gene therapy restores vision in a canine model of childhood blindness [J].

Acland, GM ;

Aguirre, GD ;

Ray, J ;

Zhang, Q ;

Aleman, TS ;

Cideciyan, AV ;

Pearce-Kelling, SE ;

Anand, V ;

Zeng, Y ;

Maguire, AM ;

Jacobson, SG ;

Hauswirth, WW ;

Bennett, J .

NATURE GENETICS, 2001, 28 (01) :92-95

[3]

Aguirre G D, 1998, Mol Vis, V4, P23

[4] Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation [J].

Aguirre, Geoffrey K. ;

Komaromy, Andras M. ;

Cideciyan, Artur V. ;

Brainard, David H. ;

Aleman, Tomas S. ;

Roman, Alejandro J. ;

Avants, Brian B. ;

Gee, James C. ;

Korczykowski, Marc ;

Hauswirth, William W. ;

Acland, Gregory M. ;

Aguirre, Gustavo D. ;

Jacobson, Samuel G. .

PLOS MEDICINE, 2007, 4 (06) :1117-1128

[5] Gene therapy in the second eye of RPE65-deficient dogs improves retinal function [J].

Annear, M. J. ;

Bartoe, J. T. ;

Barker, S. E. ;

Smith, A. J. ;

Curran, P. G. ;

Bainbridge, J. W. ;

Ali, R. R. ;

Petersen-Jones, S. M. .

GENE THERAPY, 2011, 18 (01) :53-61

[6]

Annear M. J., 2011, OPHTHALMOL VIS SCI, V52

[7] Reproducibility of an objective four-choice canine vision testing technique that assesses vision at differing light intensities [J].

Annear, Matthew J. ;

Gornik, Kara R. ;

Venturi, Francesca L. ;

Hauptman, Joe G. ;

Bartoe, Joshua T. ;

Petersen-Jones, Simon M. .

VETERINARY OPHTHALMOLOGY, 2013, 16 (05) :324-328

[8] Effect of gene therapy on visual function in Leber's congenital amaurosis [J].

Bainbridge, James W. B. ;

Smith, Alexander J. ;

Barker, Susie S. ;

Robbie, Scott ;

Henderson, Robert ;

Balaggan, Kamaljit ;

Viswanathan, Ananth ;

Holder, Graham E. ;

Stockman, Andrew ;

Tyler, Nick ;

Petersen-Jones, Simon ;

Bhattacharya, Shomi S. ;

Thrasher, Adrian J. ;

Fitzke, Fred W. ;

Carter, Barrie J. ;

Rubin, Gary S. ;

Moore, Anthony T. ;

Ali, Robin R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (21) :2231-2239

[9] Molecular Anthropology Meets Genetic Medicine to Treat Blindness in the North African Jewish Population: Human Gene Therapy Initiated in Israel [J].

Banin, Eyal ;

Bandah-Rozenfeld, Dikla ;

Obolensky, Alexey ;

Cideciyan, Artur V. ;

Aleman, Tomas S. ;

Marks-Ohana, Devora ;

Sela, Malka ;

Boye, Sanford ;

Sumaroka, Alexander ;

Roman, Alejandro J. ;

Schwartz, Sharon B. ;

Hauswirth, William W. ;

Jacobson, Samuel G. ;

Hemo, Itzhak ;

Sharon, Dror .

HUMAN GENE THERAPY, 2010, 21 (12) :1749-1757

[10] rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters [J].

Beltran, W. A. ;

Boye, S. L. ;

Boye, S. E. ;

Chiodo, V. A. ;

Lewin, A. S. ;

Hauswirth, W. W. ;

Aguirre, G. D. .

GENE THERAPY, 2010, 17 (09) :1162-1174

← 1 2 3 4 5 →